HINOON Pharmaceuticals: Major
Health Technology
Mkt Cap
51.2B
P/E (TTM)
12.77
EPS
77.92
ROE
29.09%
Div Yield
5.18%
About
Highnoon Laboratories Ltd. is a holding company, which engages in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. The company was founded in March 1984 and is headquartered in Lahore, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 27.71B | 24.64B | 19.77B | 15.82B | 13.00B | |
| Gross Profit | 14.67B | 12.13B | 9.10B | 7.92B | 6.32B | |
| Net Income | 4.13B | 3.39B | 2.45B | 2.47B | 1.86B | |
| EPS | 77.92 | 63.95 | 46.20 | 46.67 | 35.04 | |
| ROE | 32.32% | 31.04% | 27.67% | 36.44% | 35.33% | |
| ROA | 22.18% | 20.88% | 18.72% | 25.20% | 23.89% | |
| Gross Margin | 52.94% | 49.23% | 46.06% | 50.08% | 48.59% | |
| Net Margin | 14.90% | 13.75% | 12.38% | 15.63% | 14.28% | |
| Current Ratio | 3.03 | 3.02 | 3.43 | 3.31 | 3.59 | |
| DPS | 50.00 | 40.00 | 30.00 | 15.81 | 14.37 | |
| Free Cash Flow | 1.42B | 4.26B | 981.53M | -1.00B | 1.56B |